References
- Chang AE , KarnellLH, MenckHR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer83(8), 1664–1678 (1998).
- Heppt MV , RoeschA, WeideBet al. Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma. Eur. J. Cancer81, 36–44 (2017).
- Mihajlovic M , VlajkovicS, JovanovicP, StefanovicV. Primary mucosal melanomas: a comprehensive review. Int. J. Clin. Exp. Pathol.5(8), 739–753 (2012).
- Tacastacas JD , BrayJ, CohenYKet al. Update on primary mucosal melanoma. J. Am. Acad. Dermatol.71(2), 366–375 (2014).
- Little RJA . A test of missing completely at random for multivariate data with missing values. J. Am. Stat. Assoc.83, 1198–1202 (1988).
- Gilks WR , RichardsonS, SpiegelhalterDJ Markov Chain Monte Carlo in Practice. Chapman and Hall, London (1996).
- Winchester DP , StewartAK, BuraC, JonesRS. The National Cancer Data Base: a clinical surveillance and quality improvement tool. J Surg Oncol.85(1), 1–3 (2004).
- McLaughlin CC , WuXC, JemalA, MartinHJ, RocheLM, ChenVW. Incidence of noncutaneous melanomas in the U.S.Cancer103(5), 1000–1007 (2005).
- Lian B , CuiCL, ZhouLet al. The natural history and patterns of metastases from mucosal melanoma: an analysis of 706 prospectively-followed patients. Ann Oncol.28(4), 868–873 (2017).
- Bishop KD , OlszewskiAJ. Epidemiology and survival outcomes of ocular and mucosal melanomas: a population-based analysis. Int J Cancer.134(12), 2961–2971 (2014).
- Gru AA , BeckerN, DehnerLP, PfeiferJD. Mucosal melanoma: correlation of clinicopathologic, prognostic, and molecular features. Melanoma Res.24(4), 360–370 (2014).
- Keller DS , ThomayAA, GaughanJet al. Outcomes in patients with mucosal melanomas. J. Surg. Oncol.108(8), 516–520 (2013).
- Kim HS , KimEK, JunHJet al. Noncutaneous malignant melanoma: a prognostic model from a retrospective multicenter study. BMC Cancer10, 167 (2010).
- Koomen ER , de VriesE, van KempenLCet al. Epidemiology of extracutaneous melanoma in the Netherlands. Cancer Epidemiol. Biomarkers Prev.19(6), 1453–1459 (2010).
- Patrick RJ , FenskeNA, MessinaJL. Primary mucosal melanoma. J. Am. Acad. Dermatol.56(5), 828–834 (2007).
- Schaefer T , SatzgerI, GutzmerR. Clinics, prognosis and new therapeutic options in patients with mucosal melanoma: a retrospective analysis of 75 patients. Medicine96(1), e5753 (2017).
- Jethanamest D , VilaPM, SikoraAG, MorrisLG. Predictors of survival in mucosal melanoma of the head and neck. Ann. Surg. Oncol.18(10), 2748–2756 (2011).
- Owens JM , RobertsDB, MyersJN. The role of postoperative adjuvant radiation therapy in the treatment of mucosal melanomas of the head and neck region. Arch. Otolaryngol. Head Neck Surg.129(8), 864–868 (2003).
- Luna-Ortiz K , Aguilar-RomeroM, Villavicencio-ValenciaVet al. Comparative study between two different staging systems (AJCC TNM VS BALLANTYNE’S) for mucosal melanomas of the Head & Neck. Med. Oral Patol Oral Cir. Bucal.21(4), e425–e430 (2016).
- Lee SP , ShimizuKT, TranLM, JuillardG, CalcaterraTC. Mucosal melanoma of the head and neck: the impact of local control on survival. Laryngoscope104(2), 121–126 (1994).